Ads
related to: severe eczema treatment- Home
Official Patient Website—
Get Treatment Info Today.
- Treatment Support
Discover Educational Resources
& Get Financial Support Information
- FAQs
Find Answers To Your Questions
& Understand Treatment Now
- Getting Started
Learn More About Dosing Schedules
Find Answers To Your Questions
- Sign Up
Register Or Activate Your Card—
Find Out If You're Eligible Today.
- Support Resources
Sign Up And Learn More About The
Patient Education Program Today.
- Home
Search results
Eczema and healing: Itching and easing symptoms
Medical News Today· 7 days agoEczema is an inflammatory skin condition that causes inflamed, scaly, and itchy skin lesions. This article outlines the different stages of eczema and...
...Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the ...
The Pendulum· 2 days agoThe data of long-term treatment with stapokibart demonstrated sustained efficacy and favorable safety profile in adult patients with moderate-to-severe ...
Hand Rash: 12 Possible Causes and Treatment Options
Verywell Health via Yahoo News· 6 days agoA hand rash can result from allergic reactions, exposure to irritants, and sunburn. Health conditions like eczema and psoriasis can also cause hand...
Indoor tanning and eczema: Benefits, risks, and tanning tips
Medical News Today· 7 days agoModerate sun exposure and phototherapy may help improve eczema. Phototherapy uses controlled...
Keymed reports positive efficacy of stapokibart in Phase III clinical trial
Clinical Trials Arena via Yahoo Finance· 1 day agoIII clinical trial of the stapokibart injection in patients with moderate-to-severe atopic...
J&J to acquire experimental eczema drug for $1.25B
NJBIZ· 5 days agoJohnson & Johnson plans to pay $1.25 billion for the rights to an experimental eczema treatment. The New Brunswick-based pharma giant announced the...
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
Morningstar· 5 days agoThe European Commission is expected to announce a final decision on the Dupixent application in the coming months.
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 12 hours agoUNION therapeutics announces successful completion of the ADESOS Phase 2b study and presentation of data at the RAVE Conference 2024 PR Newswire HELLERUP, Denmark, June 4, 2024 ADESOS Phase ...
What to Know About Hidradenitis Suppurativa, a Lesser-Known Type of Acne
PopSugar· 1 day agoIf you're experiencing painful bumps or lesions forming under the skin, but it feels or looks...
Tapinarof Cream Effective For AD, Down to Age 2 Years
Medscape· 7 days agoResults from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old.
